These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
433 related articles for article (PubMed ID: 30847861)
1. The resting metabolic rate in women with polycystic ovary syndrome and its relation to the hormonal milieu, insulin metabolism, and body fat distribution: a cohort study. Romualdi D; Versace V; Tagliaferri V; De Cicco S; Immediata V; Apa R; Guido M; Lanzone A J Endocrinol Invest; 2019 Sep; 42(9):1089-1097. PubMed ID: 30847861 [TBL] [Abstract][Full Text] [Related]
2. [Clinical features, hormonal profile, and metabolic abnormalities of obese women with obese polycystic ovary syndrome]. Li X; Lin JF Zhonghua Yi Xue Za Zhi; 2005 Dec; 85(46):3266-71. PubMed ID: 16409817 [TBL] [Abstract][Full Text] [Related]
3. Association of fat to lean mass ratio with metabolic dysfunction in women with polycystic ovary syndrome. Ezeh U; Pall M; Mathur R; Azziz R Hum Reprod; 2014 Jul; 29(7):1508-17. PubMed ID: 24813197 [TBL] [Abstract][Full Text] [Related]
4. Bioavailable and free 25-hydroxyvitamin D and vitamin D binding protein in polycystic ovary syndrome: Relationships with obesity and insulin resistance. Naderpoor N; Shorakae S; Abell SK; Mousa A; Joham AE; Moran LJ; Stepto NK; Spritzer PM; Teede HJ; de Courten B J Steroid Biochem Mol Biol; 2018 Mar; 177():209-215. PubMed ID: 28734987 [TBL] [Abstract][Full Text] [Related]
5. Comparison of regional fat mass measurement by whole body DXA scans and anthropometric measures to predict insulin resistance in women with polycystic ovary syndrome and controls. Glintborg D; Petersen MH; Ravn P; Hermann AP; Andersen M Acta Obstet Gynecol Scand; 2016 Nov; 95(11):1235-1243. PubMed ID: 27529295 [TBL] [Abstract][Full Text] [Related]
6. Effect of long-term orlistat treatment on serum levels of advanced glycation end-products in women with polycystic ovary syndrome. Diamanti-Kandarakis E; Katsikis I; Piperi C; Alexandraki K; Panidis D Clin Endocrinol (Oxf); 2007 Jan; 66(1):103-9. PubMed ID: 17201808 [TBL] [Abstract][Full Text] [Related]
7. Effect of long-term treatment with metformin added to hypocaloric diet on body composition, fat distribution, and androgen and insulin levels in abdominally obese women with and without the polycystic ovary syndrome. Pasquali R; Gambineri A; Biscotti D; Vicennati V; Gagliardi L; Colitta D; Fiorini S; Cognigni GE; Filicori M; Morselli-Labate AM J Clin Endocrinol Metab; 2000 Aug; 85(8):2767-74. PubMed ID: 10946879 [TBL] [Abstract][Full Text] [Related]
8. Dietary glycemic index is associated with less favorable anthropometric and metabolic profiles in polycystic ovary syndrome women with different phenotypes. Graff SK; Mário FM; Alves BC; Spritzer PM Fertil Steril; 2013 Oct; 100(4):1081-8. PubMed ID: 23830153 [TBL] [Abstract][Full Text] [Related]
11. The independent effects of polycystic ovary syndrome and obesity on serum concentrations of gonadotrophins and sex steroids in premenopausal women. Holte J; Bergh T; Gennarelli G; Wide L Clin Endocrinol (Oxf); 1994 Oct; 41(4):473-81. PubMed ID: 7955458 [TBL] [Abstract][Full Text] [Related]
12. Circulating levels of obestatin and copeptin in obese and nonobese women with polycystic ovary syndrome. Taskin MI; Bulbul E; Adali E; Hismiogulları AA; Inceboz U Eur J Obstet Gynecol Reprod Biol; 2015 Jun; 189():19-23. PubMed ID: 25837320 [TBL] [Abstract][Full Text] [Related]
13. Relationship between body composition, insulin resistance, and hormonal profiles in women with polycystic ovary syndrome. Zhang H; Wang W; Zhao J; Jiao P; Zeng L; Zhang H; Zhao Y; Shi L; Hu H; Luo L; Fukuzawa I; Li D; Li R; Qiao J Front Endocrinol (Lausanne); 2022; 13():1085656. PubMed ID: 36699018 [TBL] [Abstract][Full Text] [Related]
14. Association of MEP1A gene variants with insulin metabolism in central European women with polycystic ovary syndrome. Lam UD; Lerchbaum E; Schweighofer N; Trummer O; Eberhard K; Genser B; Pieber TR; Obermayer-Pietsch B Gene; 2014 Mar; 537(2):245-52. PubMed ID: 24388959 [TBL] [Abstract][Full Text] [Related]
15. Metastin levels in relation with hormonal and metabolic profile in patients with polycystic ovary syndrome. Yilmaz SA; Kerimoglu OS; Pekin AT; Incesu F; Dogan NU; Celik C; Unlu A Eur J Obstet Gynecol Reprod Biol; 2014 Sep; 180():56-60. PubMed ID: 25020276 [TBL] [Abstract][Full Text] [Related]
16. Evaluation of the Efficacy of Sex Hormone-Binding Globulin in Insulin Resistance Assessment Based on HOMA-IR in Patients with PCOS. Chen F; Liao Y; Chen M; Yin H; Chen G; Huang Q; Chen L; Yang X; Zhang W; Wang P; Yin G Reprod Sci; 2021 Sep; 28(9):2504-2513. PubMed ID: 33721297 [TBL] [Abstract][Full Text] [Related]
17. Visceral adiposity index levels in overweight and/or obese, and non-obese patients with polycystic ovary syndrome and its relationship with metabolic and inflammatory parameters. Durmus U; Duran C; Ecirli S J Endocrinol Invest; 2017 May; 40(5):487-497. PubMed ID: 27838846 [TBL] [Abstract][Full Text] [Related]
18. Analysis of clinical characteristics in large-scale Chinese women with polycystic ovary syndrome. Shi Y; Guo M; Yan J; Sun W; Zhang X; Geng L; Xu L; Chen Z Neuro Endocrinol Lett; 2007 Dec; 28(6):807-10. PubMed ID: 18063948 [TBL] [Abstract][Full Text] [Related]
19. Body fat composition and distribution in women with polycystic ovary syndrome. Cosar E; Uçok K; Akgün L; Köken G; Sahin FK; Arioz DT; Baş O Gynecol Endocrinol; 2008 Aug; 24(8):428-32. PubMed ID: 18850379 [TBL] [Abstract][Full Text] [Related]
20. Serum lipoprotein lipid profile in women with the polycystic ovary syndrome: relation to anthropometric, endocrine and metabolic variables. Holte J; Bergh T; Berne C; Lithell H Clin Endocrinol (Oxf); 1994 Oct; 41(4):463-71. PubMed ID: 7955457 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]